ATE390122T1 - Universelle zusammensetzung zur kontrollierten wirkstofffreigabe enthaltend xanthangummi und natriumalginat - Google Patents

Universelle zusammensetzung zur kontrollierten wirkstofffreigabe enthaltend xanthangummi und natriumalginat

Info

Publication number
ATE390122T1
ATE390122T1 AT03019531T AT03019531T ATE390122T1 AT E390122 T1 ATE390122 T1 AT E390122T1 AT 03019531 T AT03019531 T AT 03019531T AT 03019531 T AT03019531 T AT 03019531T AT E390122 T1 ATE390122 T1 AT E390122T1
Authority
AT
Austria
Prior art keywords
sodium alginate
gummi
active ingredients
controlled release
ingredients containing
Prior art date
Application number
AT03019531T
Other languages
English (en)
Inventor
Adnan Ali Badwan
Mayyas Mohammad Ahma Al-Remawi
Mutaz Bellah A W Salem
Original Assignee
Jpm The Jordanian Pharmaceutic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jpm The Jordanian Pharmaceutic filed Critical Jpm The Jordanian Pharmaceutic
Application granted granted Critical
Publication of ATE390122T1 publication Critical patent/ATE390122T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03019531T 2003-09-01 2003-09-01 Universelle zusammensetzung zur kontrollierten wirkstofffreigabe enthaltend xanthangummi und natriumalginat ATE390122T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03019531A EP1510205B1 (de) 2003-09-01 2003-09-01 Universelle Zusammensetzung zur kontrollierten Wirkstofffreigabe enthaltend Xanthangummi und Natriumalginat

Publications (1)

Publication Number Publication Date
ATE390122T1 true ATE390122T1 (de) 2008-04-15

Family

ID=34089635

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03019531T ATE390122T1 (de) 2003-09-01 2003-09-01 Universelle zusammensetzung zur kontrollierten wirkstofffreigabe enthaltend xanthangummi und natriumalginat

Country Status (5)

Country Link
US (1) US20050074491A1 (de)
EP (1) EP1510205B1 (de)
JP (1) JP2005075830A (de)
AT (1) ATE390122T1 (de)
DE (1) DE60319982T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101612140B (zh) * 2009-07-13 2011-12-14 浙江金华康恩贝生物制药有限公司 一种双氯芬酸钾缓释微丸胶囊的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
US4867970A (en) * 1987-05-21 1989-09-19 E. R. Squibb & Sons, Inc. Moistureless oral drug delivery formulation and method for preparing same
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
IN186245B (de) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
WO2002041876A1 (en) * 2000-11-22 2002-05-30 Lupin Limited Pharmaceutical composition for controlled release of an active ingredient

Also Published As

Publication number Publication date
EP1510205A1 (de) 2005-03-02
EP1510205B1 (de) 2008-03-26
US20050074491A1 (en) 2005-04-07
DE60319982T2 (de) 2009-04-16
JP2005075830A (ja) 2005-03-24
DE60319982D1 (de) 2008-05-08

Similar Documents

Publication Publication Date Title
El-Kamel et al. Micromatricial metronidazole benzoate film as a local mucoadhesive delivery system for treatment of periodontal diseases
Lee et al. Thixotropic property in pharmaceutical formulations
JP5934812B2 (ja) 制御放出の製剤処方または食品処方およびその製造方法
BRPI0409336A (pt) sistema de liberação compreendendo uma pelìcula de gel termorreversìvel, homogênea, pelìcula de sistema de liberação, e, processo para preparar o sistema de liberação da mesma
WO2003074086A1 (fr) Matrice liquide a transfert de phase in vivo, et preparations liquides orales
BR0307278A (pt) Formulação oral de liberação imediata, e, método para preparar uma formulação
EP1291362A4 (de) Komplex aus folsäure und polysacchariden, dessen herstellung sowie diesen komplex als aktiven bestandteil enthaltende pharmazeutische zusammensetzung
BRPI1007161B1 (pt) Composição farmacêutica oral sólida, e, processo para preparar uma composição
NO20092662L (no) Sammensetning med forlenget frigjoring og fremgangsmate for a produsere det samme
DE602005025755D1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
EA200702520A1 (ru) Составы для изменения биофизических свойств слизистой оболочки
CY1108863T1 (el) Φαρμακευτικο σκευασμα εκτεταμενης απελευθερωσης ανεξαρτητης απο το ρη
PE20020207A1 (es) Preparaciones de liberacion controlada que comprenden derivados de quinolona y polimeros
JPWO2006123678A1 (ja) ドロキシドパを含有する安定な錠剤
ATE462410T1 (de) Selbstemulgierendes butylbenzolphthalein- arzneimittelabgabesystem, sein herstellungsverfahren und seine anwendung
CN114392250A (zh) 一种原位快速成型水凝胶皮肤敷贴及其制备方法
DE60319983D1 (de) Universelle Zusammensetzung zur kontrollierten Wirkstoffabgabe enthaltend Chitosan
HRP20100189T1 (hr) Farmaceutske formulacije koje sadrže supstancije za korekciju okusa sa poboljšanim farmaceutskim svojstvima
JP2006321792A (ja) 含水ゲル体及びその製造方法
ATE390122T1 (de) Universelle zusammensetzung zur kontrollierten wirkstofffreigabe enthaltend xanthangummi und natriumalginat
ATE407710T1 (de) Implantat für den transport und die freigabe von pharmakologisch aktiven substanzen
DK1305057T3 (da) Mikropartikelformig biomaterialesammensætning af hyaluronsyre til medicinsk anvendelse
JP2007119552A (ja) （メタ）アクリル酸系含水ゲル体の製造方法および（メタ）アクリル酸系含水ゲル
EP1986693A1 (de) Basenbildendes wirkstoffbeschichtetes silikathybrid mit basischem polymer und dessen syntheseverfahren
JO2572B1 (en) A general formula for controlled release

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties